Impact of a Stage IV NSCLC Care Pathway on Frontline and Maintenance Chemotherapy Use

James Stevenson, MD, Department of Hematology and Oncology, Cleveland Clinic, discusses the impact of a stage IV non-small cell lung cancer (NSCLC) care pathway on frontline and maintenance chemotherapy use.

Related Videos
Expert on lung cancer
Expert on NSCLC
Related Content